Biotechnology News
-
AdAlta to present at BIO International Convention
AdAlta Limited (ASX:1AD), the clinical stage biotechnology company developing novel therapeutic products from its i-body platform, is pleased to advise that CEO and Managing Director, Dr Tim Oldham, has been selected to present at the Bio International Convention in San Diego, California on Monday 13 June, US time. BIO is the world’s largest advocacy association representing member ...
-
Capricor Therapeutics Appoints Xavier Avat as Chief Business Officer
Capricor Expands Senior Management Team to Build Commercial Strategy for Lead Asset, CAP-1002, and Further Develop Partnering Strategy for Proprietary Exosome Platform Formerly at Edwards Lifesciences, Gilead and Genentech, Mr. Avat Brings Over 25 Years of Business and Commercial Strategy Experience to Capricor Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company focused on the ...
-
Defymed at the BIO International Convention in San Diego
Richard BOUAOUN our COO and Manuel Pires our BDO will attend the BIO International Convention held from June 13 to 16 in San Diego California (United States), the World’s largest gathering of biotechnology industry, along with industry-leading investor and partnering meetings held around the world. For the first time in three years the conference will be back fully in person and plan to ...
By Defymed
-
Creative Enzymes to Present at the BIO International Convention on June 13-16th, 2022
Creative Enzymes, a remarkable supplier and manufacturer in the enzymology field, today announced that members of its management team will participate in BIO International Convention on June 13-16th, 2022, in San Diego, California. BIO International Convention Details After two digital editions, BIO International Convention is happening back in person, taking place in San Diego, CA, on June ...
-
Creative Proteomics Cytokine Unveils Tumor Necrosis Factors (TNF) Detection Service
The Cytokine division belongs to Creative Proteomics, which specializes in providing cytokine research and analysis services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Creative Proteomics Cytokine recently announced the launch of the high-sensitivity Tumor Necrosis Factors (TNF) Detection Service to help with your ...
-
Research and innovation in Gesan with Smiling and Gesanbiotecno projects
Research, production and marketing are the strengths of our company, and Smiling and Gesanbiotecno projects are an excellent opportunity to enhance the concept of integration between man, environment and technology. In Gesan, R&D department is a fundamental asset for the company’s business and all activities are constantly oriented towards the production and distribution of innovative ...
-
Actym Therapeutics Announces Significant Expansion of Senior Leadership
Actym Therapeutics, a privately held biotechnology company developing STACT, a novel therapeutic platform that delivers immunomodulatory payloads to solid tumors after IV dosing, announced today the significant expansion of its senior leadership team. Dr. Julie Cherrington joins as BOD Chair, James Stutz joins as Chief Business Officer, and Dr. Omkar Joshi joins as Vice President, Technical ...
-
Genapsys Names Jason Myers CEO
Genapsys Inc. (Genapsys), the company behind the world’s first highly accurate, affordable, and accessible gene sequencer, today announced it has named Jason Myers as its Chief Executive Officer, effective February 15, 2021. He will also join the Genapsys Board of Directors. Myers will succeed Dr. Hesaam Esfandyarpour, founder and CEO of Genapsys since 2010, who will remain as Chairman.As a ...
-
Etienne Jornod, Om Pharma‘S Executive Chairman Receives Swiss Biotech Success Stories Award 2022
OM Pharma is pleased to announce that Etienne Jornod, its Executive Chairman and co-owner, has been recognised as winner of the Swiss Biotech Success Stories Awards 2022. The awards, bestowed annually by the Swiss Biotech Association, celebrates those who have made important and sustainable contributions to the biotech industry in Switzerland. The Swiss entrepreneur was particularly ...
-
Lifeasible Released Medicinal Plant Tissue Culture Service for Research Use
Lifeasible, an expert in the field of plant tissue culture that provides high quality plant tissue culture services including virus-free breeding, tissue culture solutions and a diverse range of products, recently released medicinal plant tissue culture service for scientists in the field of medicinal botany. Herbal medicine is now universally recognized around the world, especially in the ...
By Lifeasible
-
CD Genomics Releases Human Mitochondrial DNA Sequencing for Disease Research and Biodiversity Assessment
CD Genomics is a world-leading genomics services company, innovating in sequencing services for the genomics industry as well as genotyping, library construction, bioinformatics, aptamers, microarrays, health diagnostics, mutagenesis analysis, and more. CD Genomics launches fully-developed human mitochondrial DNA (mtDNA) sequencing for the study of mitochondrial genome-related diseases, such as ...
By CD Genomics
-
Kallyope, Pioneers in Drug Discovery via the Gut-Brain Axis, Adds New Chief Business Officer
Kallyope, Inc., a leading biotechnology company focused on identifying and developing therapeutics targeting the gut-brain axis, today announced the appointment of Fernando Sallés, PhD, as Chief Business Officer. Dr. Sallés joins the Kallyope senior leadership team as the company advances its pioneering drug discovery platform, clinical trials, and pipeline of multiple programs ...
-
Bio-Me Joins Microbiome Therapeutics Innovation Group
The Microbiome Therapeutics Innovation Group (MTIG) today announced the addition of Bio-Me to its coalition of companies leading the research and development of FDA-approved microbiome therapeutic drugs and microbiome-based products. Bio-Me offers a wide range of proprietary solutions to facilitate the gut microbiome analysis process for academia and pharma researchers and is setting the ...
By Bio-Me
-
Creative Enzymes Probiotics Expands Service Offering with the Launch of Lactococcus Strains
Creative Enzymes, a professional and experienced supplier of enzymes, has a great reputation in the industry. With the continuous expansion of business areas and scale, the company has set foot in other areas and established a sound probiotic production and supply chain. These days, Creative Enzymes Probiotics is excited to announce the launch of Lactococcus strains. This will further enrich the ...
-
Alfa Chemistry Launches a Chemistry-Focused Technology Platform: Advanced and Flexible
In this brand new year of 2022, Alfa Chemistry wishes to extend its sincere gratitude to its customers worldwide for their continuing support in the past years. While maintaining to be a trust-worthy supplier of all varieties of chemicals, the company decides to play a more active role in chemistry services and thus launches an advanced and flexible chemistry-focused technology platform, offering ...
-
Creative Biostructure Unveils Cryo-EM Single-particle Analysis Service
Creative Biostructure, a biotechnology company specialized in providing cost-effective contract services to both academia and biotech industries in the field of structural biology, provides a comprehensive list of cryo-em related technologies including Cryo-EM Single-Particle Analysis. Cryo-EM is an ultra-low temperature cryo-sample preparation and transfer technology (Cryo-EM) based on ...
-
Creative Proteomics Expands Service Offering With the Launch of Structure Activity Relationship (SAR) Analysis Service
Creative Proteomics, an integrated CRO company committed to providing a full range of services to support various proteome-related research projects, from the identification of single proteins to large-scale proteomic studies, has recently launched fully-developed Structure Activity Relationship (SAR) Analysis Service. SAR technology now fulfills expanding roles in handling large and expanding ...
-
Creative Proteomics Cytokine Launches High-Sensitivity Inflammation Cytokines Assay to Support Your Research
Cytokine division belongs to Creative Proteomics, which specializes in providing cytokine research and analysis services for researchers in the pharmaceutical and biotechnology industries, as well as academic institutes and government agencies. Creative Proteomics is proud to announce the launch of the high-sensitivity inflammatory cytokine assays. These assays offer ultra-sensitivity, excellent ...
-
Kallyope, Pioneers in Drug Discovery via the Gut-Brain Axis, Strengthens Senior Leadership Team with Key Appointments
Kallyope, Inc., a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis, today announced the appointments of George Shiebler as General Counsel and Anita Kawatra as Executive Vice President, Corporate Affairs, to help steer the company as it advances its pioneering drug discovery platform, clinical trials, and pipeline of multiple programs ...
-
AVM Biotechnology Expands C-Suite in Anticipation of 2023 Commercialization Efforts
AVM Biotechnology, a clinical stage company developing AVM0703, a small molecule that mobilizes endogenous gamma delta TCR+ and invariant TCR+ bispecific Natural Killer T-like cells, announced the expansion of its senior management with the appointment of Brian Andersen as Chief Commercial Officer and Pearl Chan as Chief Financial Officer. These seasoned industry leaders will help drive the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you